vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and Katapult Holdings, Inc. (KPLT). Click either name above to swap in a different company.
Katapult Holdings, Inc. is the larger business by last-quarter revenue ($73.9M vs $62.1M, roughly 1.2× Cytek Biosciences, Inc.). Katapult Holdings, Inc. runs the higher net margin — 26.8% vs -70.9%, a 97.8% gap on every dollar of revenue. On growth, Katapult Holdings, Inc. posted the faster year-over-year revenue change (17.3% vs 8.1%). Cytek Biosciences, Inc. produced more free cash flow last quarter ($-1.8M vs $-12.0M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 6.6%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Katapult Holdings, Inc. is a U.S.-based fintech company that provides accessible point-of-sale lease-to-purchase solutions for consumers with limited or no traditional credit history. It partners with a wide network of e-commerce platforms and brick-and-mortar retail merchants across segments including electronics, furniture and home goods to offer flexible payment plans for customers to obtain needed products.
CTKB vs KPLT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $73.9M |
| Net Profit | $-44.1M | $19.8M |
| Gross Margin | 52.9% | 15.6% |
| Operating Margin | -9.0% | -1.4% |
| Net Margin | -70.9% | 26.8% |
| Revenue YoY | 8.1% | 17.3% |
| Net Profit YoY | -557.1% | 307.3% |
| EPS (diluted) | — | $3.69 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $73.9M | ||
| Q3 25 | $52.3M | $74.0M | ||
| Q2 25 | $45.6M | $71.9M | ||
| Q1 25 | $41.5M | $71.9M | ||
| Q4 24 | $57.5M | $63.0M | ||
| Q3 24 | $51.5M | $60.3M | ||
| Q2 24 | $46.6M | $58.9M | ||
| Q1 24 | $44.9M | $65.1M |
| Q4 25 | $-44.1M | $19.8M | ||
| Q3 25 | $-5.5M | $-4.9M | ||
| Q2 25 | $-5.6M | $-7.8M | ||
| Q1 25 | $-11.4M | $-5.7M | ||
| Q4 24 | $9.6M | $-9.6M | ||
| Q3 24 | $941.0K | $-8.9M | ||
| Q2 24 | $-10.4M | $-6.9M | ||
| Q1 24 | $-6.2M | $-570.0K |
| Q4 25 | 52.9% | 15.6% | ||
| Q3 25 | 52.7% | 19.7% | ||
| Q2 25 | 52.3% | 15.5% | ||
| Q1 25 | 48.6% | 19.9% | ||
| Q4 24 | 58.5% | 11.8% | ||
| Q3 24 | 56.3% | 19.8% | ||
| Q2 24 | 54.6% | 16.9% | ||
| Q1 24 | 51.3% | 25.3% |
| Q4 25 | -9.0% | -1.4% | ||
| Q3 25 | -17.6% | 3.3% | ||
| Q2 25 | -23.3% | -2.0% | ||
| Q1 25 | -36.1% | -0.7% | ||
| Q4 24 | 5.2% | -7.7% | ||
| Q3 24 | -8.2% | -7.4% | ||
| Q2 24 | -18.3% | -4.5% | ||
| Q1 24 | -23.9% | 5.8% |
| Q4 25 | -70.9% | 26.8% | ||
| Q3 25 | -10.5% | -6.7% | ||
| Q2 25 | -12.2% | -10.9% | ||
| Q1 25 | -27.5% | -7.9% | ||
| Q4 24 | 16.8% | -15.2% | ||
| Q3 24 | 1.8% | -14.7% | ||
| Q2 24 | -22.4% | -11.7% | ||
| Q1 24 | -13.8% | -0.9% |
| Q4 25 | — | $3.69 | ||
| Q3 25 | — | $-0.94 | ||
| Q2 25 | — | $-1.63 | ||
| Q1 25 | — | $-1.23 | ||
| Q4 24 | — | $-2.17 | ||
| Q3 24 | — | $-2.05 | ||
| Q2 24 | — | $-1.61 | ||
| Q1 24 | — | $-0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $22.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $-38.1M |
| Total Assets | $461.5M | $107.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $22.4M | ||
| Q3 25 | $93.3M | $3.4M | ||
| Q2 25 | $75.5M | $3.7M | ||
| Q1 25 | $95.3M | $6.0M | ||
| Q4 24 | $98.7M | $3.5M | ||
| Q3 24 | $162.3M | $25.9M | ||
| Q2 24 | $177.9M | $33.7M | ||
| Q1 24 | $168.8M | $31.2M |
| Q4 25 | $341.7M | $-38.1M | ||
| Q3 25 | $378.6M | $-58.4M | ||
| Q2 25 | $377.6M | $-54.1M | ||
| Q1 25 | $379.6M | $-51.7M | ||
| Q4 24 | $395.7M | $-46.8M | ||
| Q3 24 | $385.5M | $-40.3M | ||
| Q2 24 | $389.1M | $-32.9M | ||
| Q1 24 | $392.6M | $-27.5M |
| Q4 25 | $461.5M | $107.9M | ||
| Q3 25 | $494.9M | $85.9M | ||
| Q2 25 | $493.3M | $90.6M | ||
| Q1 25 | $482.6M | $88.5M | ||
| Q4 24 | $499.5M | $93.2M | ||
| Q3 24 | $491.2M | $92.0M | ||
| Q2 24 | $483.7M | $106.6M | ||
| Q1 24 | $492.1M | $106.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $-11.9M |
| Free Cash FlowOCF − Capex | $-1.8M | $-12.0M |
| FCF MarginFCF / Revenue | -2.9% | -16.2% |
| Capex IntensityCapex / Revenue | 1.6% | 0.0% |
| Cash ConversionOCF / Net Profit | — | -0.60× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $-11.9M | ||
| Q3 25 | $-3.9M | $4.0M | ||
| Q2 25 | $108.0K | $-6.6M | ||
| Q1 25 | $-125.0K | $3.4M | ||
| Q4 24 | $2.0M | $-32.6M | ||
| Q3 24 | $13.2M | $-5.4M | ||
| Q2 24 | $6.2M | $-628.0K | ||
| Q1 24 | $4.0M | $2.0M |
| Q4 25 | $-1.8M | $-12.0M | ||
| Q3 25 | $-4.6M | $4.0M | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-974.0K | $3.4M | ||
| Q4 24 | $1.1M | $-32.6M | ||
| Q3 24 | $12.2M | $-5.4M | ||
| Q2 24 | $5.2M | $-653.0K | ||
| Q1 24 | $3.4M | — |
| Q4 25 | -2.9% | -16.2% | ||
| Q3 25 | -8.7% | 5.4% | ||
| Q2 25 | -3.2% | — | ||
| Q1 25 | -2.3% | 4.7% | ||
| Q4 24 | 1.9% | -51.8% | ||
| Q3 24 | 23.7% | -9.0% | ||
| Q2 24 | 11.0% | -1.1% | ||
| Q1 24 | 7.6% | — |
| Q4 25 | 1.6% | 0.0% | ||
| Q3 25 | 1.3% | 0.0% | ||
| Q2 25 | 3.5% | 0.0% | ||
| Q1 25 | 2.0% | 0.0% | ||
| Q4 24 | 1.6% | 0.1% | ||
| Q3 24 | 2.0% | 0.0% | ||
| Q2 24 | 2.3% | 0.0% | ||
| Q1 24 | 1.3% | 0.0% |
| Q4 25 | — | -0.60× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
KPLT
Segment breakdown not available.
